Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -0,12 (-0,30%)
2026-06-03
AKTIENPREIS
SecurityDE:12V / Veracyte, Inc.
InstitutionPhocas Financial Corp.
Latest Disclosed Ownership39,270 shares
Latest Disclosed Value $ 1,264,887
Phocas Financial Corp. reports 21.82% decrease in ownership of 12V / Veracyte, Inc.

On May 1, 2026 - Phocas Financial Corp. filed a 13F-HR form disclosing ownership of 39,270 shares of Veracyte, Inc. (DE:12V) valued at $1,044,582 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on January 26, 2026 disclosing 50,231 shares of Veracyte, Inc.. This represents a change in shares of -21.82% during the quarter. The current value of the position is $1,591,613 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F VERACYTE COM 92337F107 39,270 -10,961 -21.82 1,265 -40.21 0.1986
2026-01-26 2025-12-31 13F/A-1 VERACYTE COM 92337F107 50,231 -122 -0.24 2,115 22.34 0.2750
2026-01-21 2025-12-31 13F VERACYTE COM 92337F107 50,231 -122 2,115 0.2812
2025-11-12 2025-09-30 13F VERACYTE COM 92337F107 50,353 1,028 2.08 1,729 29.63 0.2241
2025-08-06 2025-06-30 13F VERACYTE COM 92337F107 49,325 7 0.01 1,333 -8.82 0.1917
2025-05-09 2025-03-31 13F VERACYTE COM 92337F107 49,318 -2,791 -5.36 1,462 -29.17 0.2242
2025-03-05 2024-12-31 13F/A-1 VERACYTE COM 92337F107 52,109 -410 -0.78 2,064 206,300.00 0.2757
2025-02-05 2024-12-31 13F VERACYTE COM 92337F107 7,906 -44,613 313 0.2330
2024-11-07 2024-09-30 13F VERACYTE COM 92337F107 52,519 52,519 2 0.0068
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.